{"title":"Role of Gene Mutations in Acute Myeloid Leukemia: A Review Article.","authors":"Himanshu Singh, Magesh Kumar, Himanshu Kanungo","doi":"10.1055/s-0043-1770768","DOIUrl":null,"url":null,"abstract":"<p><p>Acute myeloid leukemia (AML) is an immensely heterogeneous disease characterized by the clonal growth of promyelocytes or myeloblasts in bone marrow as well as in peripheral blood or tissue. Enhancement in the knowledge of the molecular biology of cancer and recognition of intermittent mutations in AML contribute to favorable circumstances to establish targeted therapies and enhance the clinical outcome. There is high interest in the development of therapies that target definitive abnormalities in AML while eradicating leukemia-initiating cells. In recent years, there has been a better knowledge of the molecular abnormalities that lead to the progression of AML, and the application of new methods in molecular biology techniques has increased that facilitating the advancement of investigational drugs. In this review, literature or information on various gene mutations for AML is discussed. English language articles were scrutinized in plentiful directories or databases like PubMed, Science Direct, Web of Sciences, Google Scholar, and Scopus. The important keywords used for searching databases is \"Acute myeloid leukemia\", \"Gene mutation in Acute myeloid leukemia\", \"Genetic alteration in Acute myeloid leukemia,\" and \"Genetic abnormalities in Acute myeloid leukemia.\"</p>","PeriodicalId":40142,"journal":{"name":"Global Medical Genetics","volume":"10 2","pages":"123-128"},"PeriodicalIF":1.2000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289861/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Medical Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1770768","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Acute myeloid leukemia (AML) is an immensely heterogeneous disease characterized by the clonal growth of promyelocytes or myeloblasts in bone marrow as well as in peripheral blood or tissue. Enhancement in the knowledge of the molecular biology of cancer and recognition of intermittent mutations in AML contribute to favorable circumstances to establish targeted therapies and enhance the clinical outcome. There is high interest in the development of therapies that target definitive abnormalities in AML while eradicating leukemia-initiating cells. In recent years, there has been a better knowledge of the molecular abnormalities that lead to the progression of AML, and the application of new methods in molecular biology techniques has increased that facilitating the advancement of investigational drugs. In this review, literature or information on various gene mutations for AML is discussed. English language articles were scrutinized in plentiful directories or databases like PubMed, Science Direct, Web of Sciences, Google Scholar, and Scopus. The important keywords used for searching databases is "Acute myeloid leukemia", "Gene mutation in Acute myeloid leukemia", "Genetic alteration in Acute myeloid leukemia," and "Genetic abnormalities in Acute myeloid leukemia."
急性髓性白血病(AML)是一种异质性很强的疾病,其特征是早幼粒细胞或成髓细胞在骨髓以及外周血或组织中克隆生长。癌症分子生物学知识的提高和对AML间歇性突变的认识有助于建立靶向治疗和提高临床结果的有利环境。在根除白血病起始细胞的同时,针对AML的明确异常的治疗方法的发展引起了高度的兴趣。近年来,人们对导致AML进展的分子异常有了更好的了解,分子生物学技术中新方法的应用也越来越多,这促进了研究药物的进展。在这篇综述中,讨论了AML的各种基因突变的文献或信息。英语文章在PubMed、Science Direct、Web of Sciences、Google Scholar和Scopus等大量目录或数据库中被仔细审查。检索数据库的重要关键词是“急性髓性白血病”、“急性髓性白血病基因突变”、“急性髓性白血病基因改变”和“急性髓性白血病基因异常”。